0 to $Billion CEO Backs Tiny AI Heart Attack Stock 👀 @TraderTVLive скачать в хорошем качестве

0 to $Billion CEO Backs Tiny AI Heart Attack Stock 👀 @TraderTVLive

Two CEOs. One tiny AI stock trying to rewrite heart diagnostics. On one side you’ve got Sheldon Inwentash, CEO of ThreeD Capital, a professional deal maker with multiple 0 to $Billion wins and a track record that includes backing a biotech from $0.20 to $120 on NASDAQ. On the other, Paul Duffy, CEO of AI/ML Innovations (AIML), the company he now calls “perhaps the most disruptive invention in 60 years of cardiac diagnostics” around the ECG. In this 10‑minute interview, we break down why ThreeD Capital is now the largest shareholder in AIML, how their patented MaxYield™ / CardioYield™ engine “cracks open” each heartbeat, and why both CEOs think this platform could help predict heart‑attack risk earlier and at massive global scale. What you’ll learn in this video Why a 0 to $Billion deal maker says AIML may be his top public holding right now. How AIML’s AI doesn’t just count pulses like typical wearables, but labels the P‑wave, QRS complex and T‑wave beat‑by‑beat to build a time‑series “data wall” of your heart. Why this device‑agnostic stack can plug into hundreds of existing ECG devices and both regulated (clinical) and unregulated (wellness / longevity) markets. What AIML’s CEOs mean when they say it could be the biggest heart‑diagnostics leap in 60 years—and how that might translate into value if they execute. Upcoming catalysts: regulatory clearances (FDA, Health Canada, Jamaica), new commercial deals, and the path to revenue break‑even. The longer‑term “super‑signal” vision: using the same engine not just for the heart, but for brain, blood glucose and other signals, across both consumer wearables and regulated environments. Timestamps 00:00 – Two CEOs, One Tiny AI Heart‑Tech Stock 00:25 – ThreeD Capital’s 60‑Name Portfolio & Why AIML Stands Out 01:10 – From 20¢ to $120: Sheldon’s Past Biotech Win & Why AIML Feels Familiar 02:05 – “Most Disruptive Heart Breakthrough in 60 Years” – What Did AIML Invent? 03:10 – MaxYield & CardioYield: Cracking Open Each Heartbeat, Not Just Counting Pulses 04:20 – Device‑Agnostic AI: Plugging Into Existing ECGs & Wellness Platforms 05:05 – Why ThreeD Thinks AIML Is Deeply Undervalued Right Now 06:00 – Near‑Term Catalysts: FDA, Health Canada, Jamaica & First Clinical Deals 07:15 – Path to Profitability: Lean Cost Base, 3–5 Deals to Break Even 08:05 – The 3‑Year Vision: Super‑Signal for Heart, Brain, Glucose & More 09:15 – Final Thoughts: What Success Looks Like for AIML & ThreeD Capital ThreeD Capital is a Merchant Bank that gives investors significant exposure to early stage growth companies that most cannot even touch. ThreeD is "like an ETF" for disruptive companies. To get exposure/invest into the companies mentioned on the channel, is typically only possible by buying ThreeD Capital shares, who purchased "founder shares" in these companies, often 5-10 years ago... Join the conversation and chatroom on stocktwits - https://stocktwits.com/symbol/IDKFF let us know your favourite ThreeD Investments and what you want to see more of there! To trade in ThreeD Capital shares; go to your investing/brokerage app or sign up to one (e.g. Interactive brokers) use a referral link if you want; https://ibkr.com/referral/hector769 - phone in/search for ThreeD Capital. Found also under Tickers; $IDK on the Canadian Securities Exchange, $IDKFF on the OTC Markets, $B5K3 on the Frankfurt Borse. Find out more on our website and follow us on socials ⬇️⬇️⬇️ https://beacons.ai/threedcapital Disclaimer This video doesn't include all our investments.